XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Oct. 28, 2023
Oct. 29, 2022
Cash flows from operating activities    
Net income $ 55,620 $ 85,719
Adjustments to reconcile net income to cash provided by operating activities    
(Gain)/loss on disposal and impairment of assets 559 1
(Gain)/loss on sale of investments (1,136) 77
Provision for doubtful accounts 44 694
Depreciation and amortization 25,092 19,258
Amortization of right-of-use lease assets 37,285 38,580
Lease impairment/(settlement) (1,175) 0
Equity-based compensation expense 7,337 5,079
Change in deferred taxes (340) 27
Change in receivables (9,843) 19,550
Change in inventories 9,757 (36,771)
Change in other assets (1,361) 4,890
Change in payables (4,040) 8,027
Change in lease liabilities (38,121) (39,380)
Change in other liabilities (22,802) (74,797)
Net cash provided by operating activities 56,876 30,954
Cash flows from investing activities    
Proceeds from disposals of assets 4,037 63
Capital expenditures (26,501) (40,442)
Purchases of investments (17,485) (4,714)
Proceeds from sales of investments 21,956 12,660
Acquisitions (7,311) (11,705)
Net cash used for investing activities (25,304) (44,138)
Cash flows from financing activities    
Payments on debt and finance lease liabilities (206) (61)
Holdback payments for acquisitions (5,000) (5,000)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes (1,859) (1,711)
Repurchases of common stock (20,014) (5,004)
Dividends paid to shareholders (15,632) (14,161)
Dividends paid to minority interest joint venture partners [1] (1,172) 0
Net cash used for financing activities (43,883) (25,937)
Effect of exchange rate changes on cash and equivalents (900) (1,841)
Change in cash, cash equivalents and restricted cash (13,211) (40,962)
Cash, cash equivalents and restricted cash at beginning of period 346,678 248,856
Cash, cash equivalents and restricted cash at end of period 333,467 207,894
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 3,079 $ 4,251
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested